Acutus Medical, Inc. (AFIB) Q1 2022 Earnings Call

Investor webinar replay

Replay transcript excerpt

Thank you for standing by, and welcome to the Accurates Medical, Inc. First Quarter 2022 Earnings Conference Call. At this time, all participants are in listen-only mode. After the presentation, we will conduct a question and answer session. To ask a question during the session, you will need to press star 1 on your telephone. If you require any further assistance, please press star 0. I would now like to hand the conference over to your speaker today, Carolyn Corner. Thank you, Operator. Welcome to ACUTUS's first quarter 2022 earnings call. Joining me on today's call are Scott Henneken, Chairman of ACUTUS's Board of Directors, and David Roman, Interim Chief Executive Officer and Chief Financial Officer. This call will include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements made on this call that do not relate to matters of historical fact should be considered forward-looking statements. Factors that may cause results to differ from those forward-looking statements are discussed under the forward-looking statement section in the press release attached as an exhibit to ACUTUS's Form 8-K filed with the SEC today and are also discussed in more detail under the risk factors section in ACUTUS's most recent filing for the SEC, including the risk factors described in ACUTUS's Form 10-K. Any forward-looking statements provided during this call, including projections for future performance, are based on management's expectations as of today. ACUTUS undertakes no obligation to update these statements except as required by applicable law. ACUTUS's press release with first quarter 2022 results is also available on the ACUTUS website, www.acutusmedical.com, under the Investor section, and includes additional de...